Nurse Practitioner, Primary Care · Schenectady, NY
NPI
1831754787
Since 2019
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1201 Nott St Ste 203
Schenectady, NY, 12308
Phone (518) 374-4207
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
215 services
Medicare patients, 2024
128
Average age 71
Drug cost, 2024
$435K
1,130 prescriptions
Company payments, 2025
$452
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle C Dixon was code 99232 (hospital e&m - subsequent), 52 times for 35 patients. In total Michelle C Dixon billed 215 services in 12 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 52 | 35 | $50.48 | $2,625 |
| 90935 Hemodialysis | Facility | 35 | 25 | $45.45 | $1,591 |
| 99222 Hospital E&M - Initial | Facility | 33 | 31 | $81.77 | $2,698 |
| 90960 ESRD Related Services (not dialysis) | Office | 32 | 29 | $226.60 | $7,251 |
| 99214 Office E&M - Established | Office | 22 | 21 | $82.55 | $1,816 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 20 | $10.59 | $222 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle C Dixon prescribed most often to Medicare patients was Sevelamer Carbonate, with 109 prescriptions and refills. In total Michelle C Dixon wrote 1,130 Medicare prescriptions that cost $435K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 109 | 205 | 39 | $30K |
| Furosemide Generic | 58 | 128 | 23 | $287 |
| Farxiga Dapagliflozin Propanediol | 47 | 79 | Under 11 | $43K |
| Velphoro Sucroferric Oxyhydroxide | 45 | 61 | 15 | $180K |
| Irbesartan Generic | 44 | 92 | 11 | $1,109 |
| Allopurinol Generic | 42 | 100 | 11 | $291 |
| Bumetanide Generic | 40 | 65 | Under 11 | $932 |
| Lisinopril Generic | 37 | 87 | 14 | $245 |
| Amlodipine Besylate Generic | 33 | 97 | 15 | $300 |
| Kerendia Finerenone | 32 | 54 | Under 11 | $34K |
| Torsemide Generic | 31 | 49 | Under 11 | $256 |
| Gabapentin Generic | 30 | 46 | Under 11 | $484 |
| Losartan Potassium Generic | 26 | 56 | 11 | $248 |
| Metoprolol Succinate Generic | 26 | 66 | Under 11 | $507 |
| Lokelma Sodium Zirconium Cyclosilicate | 26 | 47 | Under 11 | $44K |
Brand drugs: 220 claims; generic drugs: 910 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle C Dixon $452 ($452 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $164.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 7 | $164 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $58.95 |
| Mallinckrodt Hospital Products Inc. | 1 | $32.52 |
| Vifor Pharma, Inc. | 1 | $30.25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $28.89 |
| Akebia Therapeutics Inc AKBA | 1 | $28.58 |
| Travere Therapeutics, Inc. TVTX | 1 | $25.4 |
| Calliditas Therapeutics US Inc. | 1 | $25.37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.85 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $19.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.